Literature DB >> 32992102

First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.

Sneha Tandon1, Mary Shago2, Scott Davidson3, Nisha Kanwar3, Fabio Fuligni3, Adam Shlien2, James Whitlock4, Anita Villani4, Oussama Abla4.   

Abstract

Infant acute lymphoblastic leukemia (ALL) comprises 2.5%-5% of pediatric ALL with inferior survival compared to older children. A majority of infants (80%) with ALL harbor KMT2A gene rearrangement, which portends a poor prognosis. Approximately 94 different partner genes have been identified to date. The common rearrangements include t(4;11)(q21;q23)KMT2A-AFF1,t(11;19) (q23;p13.3)KMT2A-MLLT1 and t(9;11)(p22;q23)KMT2A-MLLT3. We report a novel translocation t(5;11)(q35;q23)KMT2A-MAML1 in newly diagnosed infant precursor B-ALL. Long-term follow-up and a larger number of patients are needed to better understand its prognostic significance.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute leukemia; Infant leukemia; KMT2A-MAML1, Hematologic malignancies

Mesh:

Substances:

Year:  2020        PMID: 32992102     DOI: 10.1016/j.cancergen.2020.09.004

Source DB:  PubMed          Journal:  Cancer Genet


  1 in total

1.  Expanding the spectrum of mesenchymal neoplasms with NR1D1-rearrangement.

Authors:  Maribel D Lacambra; Cristina R Antonescu; Chit Chow; Wang Kei Chiu; Elizabeth G Demicco; Peter C Ferguson; David Swanson; Ka-Fai To; Lei Zhang; Brendan C Dickson
Journal:  Genes Chromosomes Cancer       Date:  2022-03-16       Impact factor: 4.263

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.